I am the head of the Department of Medical Physics’ Diagnostic X-Ray Quality Assurance Laboratory section, which is responsible for the quality assurance of all x-ray units, ultrasound equipment, and peripheral systems throughout our main campus and regional facilities.
I am a diplomate of the American Board of Radiology, certified in both diagnostic physics and nuclear medicine physics. I earned an undergraduate degree in electrical engineering from Istanbul Technical University and a master’s degree in biomedical engineering from Bogazici University, both in Turkey. I joined Memorial Sloan Kettering in 1995 as a postdoctoral fellow after completing a doctorate in medical engineering and physics at George Washington University in Washington, D.C.
My postdoctoral research focused on positron emission tomography (PET), a type of imaging that is used to obtain functional information. Later, my work led to the incorporation of functional information into external-beam radiation treatment planning, augmenting the anatomical information acquired from computed tomography (CT) scans. My current research interests include dosimetric comparison of CT scanners and investigation of x-ray tube life.
Disclosures
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Yusuf E. Erdi discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
The information published here is a complement to other publicly reported data and is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2023 through disclosure submission in spring 2024). This data reflects interests that may or may not still exist. This data is updated annually.
Learn more about MSK’s COI policies here. For questions regarding MSK’s COI-related policies and procedures, email MSK’s Compliance Office at [email protected].
View all disclosures